Genomic Disorders in Psychiatry—What Does the Clinician Need to Know?

@article{Lowther2017GenomicDI,
  title={Genomic Disorders in Psychiatry—What Does the Clinician Need to Know?},
  author={Chelsea Lowther and Gregory Costain and Danielle A Baribeau and Anne S. Bassett},
  journal={Current Psychiatry Reports},
  year={2017},
  volume={19},
  pages={1-10}
}
Purpose of ReviewThe purpose of this review is to summarize the role of genomic disorders in various psychiatric conditions and to highlight important recent advances in the field that are of potential clinical relevance.Recent FindingsGenomic disorders are caused by large rare recurrent deletions and duplications at certain chromosomal “hotspots” (e.g., 22q11.2, 16p11.2, 15q11-q13, 1q21.1, 15q13.3) across the genome. Most overlap multiple genes, affect development, and are associated with… Expand
Defining the Genetic, Genomic, Cellular, and Diagnostic Architectures of Psychiatric Disorders
TLDR
This review focuses on the findings that have illuminated the genetic architecture of psychiatric disorders and the challenges of using these findings to inform the understanding of pathophysiology. Expand
The genomics of schizophrenia: Shortcomings and solutions
TLDR
The existing literature on the genomics of schizophrenia is assessed, identifying the strengths and study design shortcomings from the following aspects: elucidation of the pathogenesis, early risk prediction and diagnosis, and the treatment of schizophrenia, and proposed solutions to overcome the shortcomings of past studies are proposed. Expand
Differences in the importance of microcephaly, dysmorphism, and epilepsy in the detection of pathogenic CNVs in ID and ASD patients
TLDR
Dysmorphism, microcephaly, and epilepsy increase the probability of pathogenic CNV findings in ID and ASD patients, and the efficacy of CNV analysis is limited in these patients. Expand
CNVs and Chromosomal Aneuploidy in Patients With Early-Onset Schizophrenia and Bipolar Disorder: Genotype-Phenotype Associations
TLDR
The association of the PAK2, ARHGAP11B, and PRODH genes with schizophrenia and/or bipolar disorder is supported and the first study of CNVs in EOS and EOB patients in Slovenia is conducted. Expand
A large data resource of genomic copy number variation across neurodevelopmental disorders
TLDR
This is the first genome-wide CNV analysis across autism spectrum disorder, attention deficit hyperactivity disorder, schizophrenia, and obsessive-compulsive disorder at once, and it is demonstrated that CNVs impacting the same genes could potentially contribute to the etiology of multiple NDDs. Expand
Rare structural variants in the DOCK8 gene identified in a cohort of 439 patients with neurodevelopmental disorders
TLDR
A clinical relevance, in terms of influencing the psychiatric clinical picture of patients, is proposed for the CNVs disrupting the DOCK8 gene, regardless of whether it is a deletion or duplication. Expand
Role of Copy Number Variations in ADHD
Copy number variations (CNV) have an important role in etiology of neurodevelopmental disorders (NDD). Among them, individuals with attention-deficit and hyperactivity disorders (ADHD) have 1.33Expand
Deletion at 12q12 increases the risk of developmental delay and intellectual disability
TLDR
A Chinese girl with a 3.18‐Mb deletion at 12q12 who showed postnatal growth delay, low‐set ears, small hands and feet, widely spaced nipples, and blue sclerae is identified, suggesting that a CNV in this region is a risk factor for developmental retardation and ID. Expand
Enrichment of rare copy number variation in children with developmental language disorder
TLDR
It is provided further evidence that rare CNVs contribute to the etiology of DLD in loci that overlap with other NDDs and families with DLD should be offered molecular genetic testing as a routine in their clinical follow‐up. Expand
Rare copy number variations affecting the synaptic gene DMXL2 in neurodevelopmental disorders
TLDR
Disruption of DMXL2 may predispose to NDDs including autism spectrum disorder, and the robust interpretation of private variants requires a multifaceted approach that incorporates multigenerational pedigrees and genome-wide and population-scale data. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 103 REFERENCES
Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era
TLDR
This review critically appraises recent developments in the field of schizophrenia genetics through the lens of immediate clinical applicability, and uses 22q11.2 deletion syndrome as a model to chart the pathway for translating emerging genetic discoveries into clinical practice. Expand
Neuropsychiatric aspects of 22q11.2 deletion syndrome: considerations in the prenatal setting
TLDR
An outline of the lifetime neuropsychiatric phenotype of 22q11.2 deletion syndrome is provided that will be useful to clinicians involved in prenatal diagnosis and related genetic counselling. Expand
Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease.
TLDR
These initial genome-wide studies of CNVs provide replicated associations of schizophrenia with rare 1q21.1 and 15q13.3 deletions and point to a more general mutational mechanism involving rare CNVs that elevate risk for schizophrenia, especially more developmental forms of the disease. Expand
Chromosomal microarray testing in adults with intellectual disability presenting with comorbid psychiatric disorders
Chromosomal copy-number variations (CNVs) are a class of genetic variants highly implicated in the aetiology of neurodevelopmental disorders, including intellectual disabilities (ID), schizophreniaExpand
Update on the 22q11.2 deletion syndrome and its relevance to schizophrenia
TLDR
Progress in characterizing and predicting psychotic illness in 22q11.2DS supports this identifiable subpopulation as a molecular model with important implications for understanding the pathogenesis of schizophrenia in the general population and for development of potential novel therapies. Expand
Adult neuropsychiatric expression and familial segregation of 2q13 duplications
  • G. Costain, A. C. Lionel, +5 authors A. Bassett
  • Biology, Medicine
  • American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
  • 2014
TLDR
Large rare 2q13 duplications appear to be associated with variable adult neuropsychiatric and other expression, and there are implications for other emerging genomic disorders where there is interest in lifelong expression. Expand
Tourette syndrome is associated with recurrent exonic copy number variants
TLDR
Rare, recurrent exonic copy number variants are associated in a subset of patients with Tourette syndrome, suggesting that these CNVs produce a continuum of neuropsychiatric disturbances that manifest in different ways depending on other genetic, environmental, or stochastic factors. Expand
Advancing epilepsy genetics in the genomic era
TLDR
The rapid pace of gene discovery in epilepsy, as facilitated by genomic technologies, is discussed, and several novel genes and potential therapies are highlighted. Expand
Uncovering obsessive-compulsive disorder risk genes in a pediatric cohort by high-resolution analysis of copy number variation
TLDR
The findings suggest that rare CNVs of at least 15 kb in size may contribute to the etiology of OCD. Expand
Identifying Potential Regions of Copy Number Variation for Bipolar Disorder
TLDR
The goal of the present study is to perform a series of data filtering and analysis procedures using a DNA pooling strategy to identify potential CNV regions that are related to bipolar disorder and to reduce the chance of false-positive findings. Expand
...
1
2
3
4
5
...